Volume 7, Issue 3 ( Journal of Clinical and Basic Research (JCBR) 2023)
jcbr 2023, 7(3): 7-11 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Vosough S, Kaghazi A. Evaluation of maternal and neonatal outcomes of pregnant women with COVID-19 at Sayad Shirazi Hospital, Gorgan, in 2020-2022. jcbr 2023; 7 (3) :7-11
URL: http://jcbr.goums.ac.ir/article-1-410-en.html
URL: http://jcbr.goums.ac.ir/article-1-410-en.html
1- Department of Obstetrics and Gynecology, Sayad Shirazi Hospital, Golestan University of Medical Sciences, Gorgan, Iran
2- Department of Obstetrics and Gynecology, Sayad Shirazi Hospital, Golestan University of Medical Sciences, Gorgan, Iran ,Azadeh.kaghazi@gmail.com
2- Department of Obstetrics and Gynecology, Sayad Shirazi Hospital, Golestan University of Medical Sciences, Gorgan, Iran ,
Abstract: (1603 Views)
Background: The coronavirus disease 2019 (COVID-19) can have a variety of effects on pregnant women, from mild symptoms to severe complications. Those with underlying medical conditions are at an increased risk for severe disease and adverse pregnancy outcomes. This study was designed to investigate the maternal and neonatal outcomes of pregnant mothers infected with COVID-19 who were referred to Sayad Shirazi Hospital, Gorgan (Iran), in 2019-2022.
Methods: This cross-sectional study was conducted on 160 pregnant women. The women who had just given birth were either suspected of having coronavirus or had a definite diagnosis of coronavirus either during hospitalization or during hospitalization who were included by the simple census. The data were collected from medical records and through telephone interviews. The chi-square test was used to compare categorical variables between the groups. The qualitative data were evaluated with quantitative variables by the analysis of variance. The significance level was less than 0.05.
Results: The difference in the access of minorities to medical and health service centers affected the pregnancy results (P=019 (. A high rate of Cesarean delivery (58.1%), a high prevalence of gestational diabetes (19.3%) and hypothyroidism (21.2%), and the need for high insulin injections during the COVID-19 infection (39.37%) were also found, which were independent of the patients. Diabetes and previous gestational diabetes showed high statistics.
Conclusion: This study demonstrated a high concentration in people with hypothyroidism and patients who need insulin due to hyperglycemia after contracting COVID-19 during pregnancy. According to this study, contracting COVID-19 increases the level of maternal and fetal problems, and women with hypothyroidism should be considered as a risk factor for contracting this disease and having a more serious condition, hyperglycemia, and the need for insulin, except for the remaining complications of this disease is expected.
Methods: This cross-sectional study was conducted on 160 pregnant women. The women who had just given birth were either suspected of having coronavirus or had a definite diagnosis of coronavirus either during hospitalization or during hospitalization who were included by the simple census. The data were collected from medical records and through telephone interviews. The chi-square test was used to compare categorical variables between the groups. The qualitative data were evaluated with quantitative variables by the analysis of variance. The significance level was less than 0.05.
Results: The difference in the access of minorities to medical and health service centers affected the pregnancy results (P=019 (. A high rate of Cesarean delivery (58.1%), a high prevalence of gestational diabetes (19.3%) and hypothyroidism (21.2%), and the need for high insulin injections during the COVID-19 infection (39.37%) were also found, which were independent of the patients. Diabetes and previous gestational diabetes showed high statistics.
Conclusion: This study demonstrated a high concentration in people with hypothyroidism and patients who need insulin due to hyperglycemia after contracting COVID-19 during pregnancy. According to this study, contracting COVID-19 increases the level of maternal and fetal problems, and women with hypothyroidism should be considered as a risk factor for contracting this disease and having a more serious condition, hyperglycemia, and the need for insulin, except for the remaining complications of this disease is expected.
Article Type: Research |
Subject:
Obstetrics and Gynecology
References
1. Rasmussen SA, Jamieson DJ. COVID-19 and Pregnancy. Infect Dis Clin North Am. 2022;36(2):423-33. [View at Publisher] [DOI] [PMID] [Google Scholar]
2. Wang H, Li N, Sun C, Guo X, Su W, Song Q, et al. The association between pregnancy and COVID-19: A systematic review and meta-analysis. Am J Emerg Med. 2022;56:188-95.
https://doi.org/10.1016/j.ajem.2021.08.054 [View at Publisher] [DOI] [PMID] [Google Scholar]
3. Kumar D, Verma S, Mysorekar IU. COVID-19 and pregnancy: clinical outcomes; mechanisms, and vaccine efficacy. Transl Res. 2023;251:84-95. [View at Publisher] [DOI] [PMID] [Google Scholar]
4. Allotey J, Stallings E, Bonet M, Yap M, Chatterjee S, Kew T, et al. Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis. BMJ. 2020;370:m3320. [View at Publisher] [DOI] [PMID] [Google Scholar]
5. CDC. Pregnant and Recently Pregnant People: At Increased Risk for Severe Illness from COVID-19. Centers for Disease Control and Prevention; 2022. [View at Publisher]
6. Giuliani F, Deantoni S, Papageorghiou AT. Vaginal vs cesarean delivery for COVID-19 in pregnancy. Am J Obstet Gynecol. 2023;228(3):358-9. [View at Publisher] [DOI] [PMID] [Google Scholar]
7. Panagiotakopoulos L, Myers TR, Gee J, Lipkind HS, Kharbandaet EO, Ryan DS, al. SARS-CoV-2 Infection Among Hospitalized Pregnant Women: Reasons for Admission and Pregnancy Characteristics-Eight U.S. Health Care Centers, March 1-May 30, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(38):1355-9. [View at Publisher] [DOI] [PMID] [Google Scholar]
8. Yang Z, Liu Y. The impact of the coronavirus disease pandemic on the mental health of pregnant women. J matern Fetal Neonatal Med. 2020;33(18):3456-9. [View at Publisher]
9. Dionne-Odom J, Klipstein S. The Impact of Epidemiology on Fertility and Prenatal Care During the COVID-19 Pandemic. Am J Epidemiol. 2021;190(5):701-6. [View at Publisher] [DOI] [PMID] [Google Scholar]
10. Elliot AJ, Harcourt SE, Hughes HE, Loveridge P, Morbey RA, Smith S, et al. The COVID-19 pandemic: a new challenge for syndromic surveillance. Epidemiol Infect. 2020;148:e122. [View at Publisher] [DOI] [PMID] [Google Scholar]
11. Ko JY, DeSisto CL, Simeone RM, Ellington S, Galang RR, Oduyebo T, et al. Adverse Pregnancy Outcomes, Maternal Complications, and Severe Illness Among US Delivery Hospitalizations With and Without a Coronavirus Disease 2019 (COVID-19) Diagnosis. Clin Infect Dis. 2021;73(Suppl 1):S24-31. [View at Publisher] [DOI] [PMID] [Google Scholar]
12. Khojah HMJ. Community pharmacy services and preparedness during COVID-19 outbreak in Madinah, Saudi Arabia. Saudi Pharm J. 2020;28(11):1402-7. [View at Publisher] [DOI] [PMID] [Google Scholar]
13. Munnoli PM, Nabapure S, Yeshavanth G. Post-COVID-19 precautions based on lessons learned from past pandemics: a review. Z Gesundh Wiss. 2022;30(4):973-81. [View at Publisher] [DOI] [PMID] [Google Scholar]
14. Collart C, Craighead C, Rose S, Frankel R, Tucker Edmonds B, Perni U, et al. The Impact of Outpatient Prenatal Care Visitor Restrictions on Pregnant Patients and Partners During the COVID-19 Pandemic. Womens Health Rep (New Rochelle). 2022;3(1):718-27. [View at Publisher] [DOI] [PMID] [Google Scholar]
15. Zambrano LD, Ellington S, Strid P, Galang RR, Oduyebo T, Tong VT, et al. Update: Characteristics of Symptomatic Women of Reproductive Age with Laboratory-Confirmed SARS-CoV-2 Infection by Pregnancy Status - United States, January 22-October 3, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(44):1641-7. [View at Publisher] [DOI] [PMID] [Google Scholar]
16. Westhoff WJ, Smith LH, Wyszynski DF, Hernandez-Diaz S. COVID-19 pharmacotherapy utilization patterns during pregnancy: International Registry of Coronavirus Exposure in Pregnancy. Pharmacoepidemiol Drug Saf. 2022;31(7):804-9. [View at Publisher] [DOI] [PMID] [Google Scholar]
17. Dollinger S, Zlatkin R, Jacoby C, Shmueli A, Barbash-Hazan S, Chen R, et al. Clinical Characteristics and Outcomes of COVID-19 During Pregnancy-a Retrospective Cohort Study. Reprod Sci. 2022;29(8):2342-9. [View at Publisher] [DOI] [PMID] [Google Scholar]
18. Trocado V, Silvestre-Machado J, Azevedo L, Miranda A, Nogueira-Silva C. Pregnancy and COVID-19: a systematic review of maternal, obstetric and neonatal outcomes. J Matern Fetal Neonatal Med. 2022;35(12):2362-74. [View at Publisher] [DOI] [PMID] [Google Scholar]
19. Khanijahani A, Iezadi S, Gholipour K, Azami-Aghdash S, Naghibi D. A systematic review of racial/ethnic and socioeconomic disparities in COVID-19. Int J Equity Health. 2021;20(1):248. [View at Publisher] [DOI] [PMID] [Google Scholar]
20. Mackey K, Ayers CK, Kondo KK, Saha S, Advani SM, Young S, et al. Racial and Ethnic Disparities in COVID-19-Related Infections, Hospitalizations, and Deaths : A Systematic Review. Ann Intern Med. 2021;174(3):362-73. [View at Publisher] [DOI] [PMID] [Google Scholar]
21. Abate G, Kapoor A, Charbek E, Beck B, Wang Q, Wang GC, et al. Effects of race on the outcome of COVID-19 in hospitalized patients. J Natl Med Assoc. 2022;114(1):56-68. [View at Publisher] [DOI] [PMID] [Google Scholar]
22. Teng W, Shan Z, Patil-Sisodia K, Cooper DS. Hypothyroidism in pregnancy. Lancet Diabetes Endocrinol. 2013;1(3):228-37. [View at Publisher] [DOI] [PMID] [Google Scholar]
23. Chen Z, Schmid SL. Evolving models for assembling and shaping clathrin-coated pits. J Cell Biol. 2020;219(9):e202005126. [View at Publisher] [DOI] [PMID] [Google Scholar]
24. Weiwei D, Bei W, Hong W, Cailan W, Hailin S, Donghong X, et al. Thyroid Hormone Changes in the Northern Area of Tianjin during the COVID-19 Pandemic. Int J Endocrinol. 2022;2022:5720875.
https://doi.org/10.1155/2022/5720875 [View at Publisher] [DOI] [PMID] [Google Scholar]
25. Akgül F, Tüzer C, Arslan Y, Sevim B. COVID-19 infection during pregnancy: A retrospective study in a city in the Southeastern region of Turkey. Saudi Med J. 2023;44(3):268-76. [View at Publisher] [DOI] [PMID] [Google Scholar]
26. Wragge-Morley A. Imagining the soul: Thomas Willis (1621-1675) on the anatomy of the brain and nerves. Prog Brain Res. 2018;243:55-73. [View at Publisher] [DOI] [PMID] [Google Scholar]
27. Camus D. Infection par le virus Zika : quels conseils en situation post-épidémique ? [Zika virus infection: what advice in post-epidemic situation?]. Rev Prat. 2020;70(3):329-32. [View at Publisher] [PMID] [Google Scholar] [Google Scholar]
28. Whittaker E, Bamford A, Kenny J, Kaforou M, Jones CE, Shah P, et al. Clinical Characteristics of 58 Children With a Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2. JAMA. 2020;324(3):259-69. [View at Publisher] [DOI] [PMID] [Google Scholar]
29. Khunti K, Del Prato S, Mathieu C, Kahn SE, Gabbay RA, Buse JB. COVID-19, Hyperglycemia, and New-Onset Diabetes. Diabetes Care. 2021;44(12):2645-55. [View at Publisher] [DOI] [PMID] [Google Scholar]
30. Gerganova A, Assyov Y, Kamenov Z. Stress Hyperglycemia, Diabetes Mellitus and COVID-19 Infection: Risk Factors, Clinical Outcomes and Post-Discharge Implications. Front Clin Diabetes Healthc. 2022;3:826006. [View at Publisher] [DOI] [PMID] [Google Scholar]
31. Pal R, Bhadada SK. COVID-19 and diabetes mellitus: An unholy interaction of two pandemics. Diabetes Metab Syndr. 2020;14(4):513-7. [View at Publisher] [DOI] [PMID] [Google Scholar]
32. Aon M, Alsaeedi A, Alzafiri A, Al-Shammari A, Taha S, Al-Shammari O, et al. Stress Hyperglycemia Ratio as a Prognostic Marker in Diabetic Patients Hospitalized with COVID-19. Infect Dis Rep. 2022;14(5):675-85. [View at Publisher] [DOI] [PMID] [Google Scholar]
33. IDF Diabetes Atlas. Diabetes around the world in 2021. 2021. [View at Publisher] [Google Scholar]
34. Jafari-Shobeiri M, Ghojazadeh M, Azami-Aghdash S, Naghavi-Behzad M, Piri R, Pourali-Akbar Y, et al. Prevalence and Risk Factors of Gestational Diabetes in Iran: A Systematic Review and Meta-Analysis. Iran J Public Health. 2015;44(8):1036-44. [View at Publisher] [PMID] [Google Scholar]
35. Delpisheh M, Firouzkouhi M, Rahnama M, Badakhsh M, Abdollahimohammad A. Prevalence of Gestational Diabetes Mellitus in Iran: A Systematic Review and Meta-Analysis Study. J Diabetes Nurs. 2022;10(2):1872-85. [View at Publisher] [Google Scholar]
36. Kleinwechter HJ, Weber KS, Mingers N, Ramsauer B, Schaefer-Graf UM, Groten T, et al. Gestational diabetes mellitus and COVID-19: results from the COVID-19-Related Obstetric and Neonatal Outcome Study (CRONOS). Am J Obstet Gynecol. 2022;227(4):631.e1-19. [View at Publisher] [DOI] [PMID] [Google Scholar]
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0).